Supplementary Figure S8 from Molecular Characterization of Residual Muscle-Invasive Bladder Cancer Identifies a Scar-Like Transcriptomic Profile with Favorable Prognosis after Neoadjuvant Therapy | Synapse
October 2, 2025Open Access
Supplementary Figure S8 from Molecular Characterization of Residual Muscle-Invasive Bladder Cancer Identifies a Scar-Like Transcriptomic Profile with Favorable Prognosis after Neoadjuvant Therapy
Key Points
Scar-like transcriptomic profiles are associated with favorable outcomes in muscle-invasive bladder cancer after treatment.
Quantitative immunohistochemistry scoring distinguished these scar-like cases from other samples in the ABACUS cohort.
The analysis highlighted the importance of transcriptomic classifiers in predicting prognosis post-neoadjuvant therapy.
The findings underline the potential for tailored treatment approaches based on transcriptomic characterization.
Abstract
Figure S8. Comparing quantitative immunohistochemistry (IHC) scores between scar-like cases identified by the transcriptomic classifier (TC) and remaining samples from the ABACUS cohort.